Blog
RSS FeedPosted by Michael Wonder on 14 Feb 2021
Does NICE influence the adoption and uptake of generics in the UK?
14 February 2021 - The aim of this paper is to examine generic competition in the UK, with a special focus ...
Posted by Michael Wonder on 22 Nov 2019
Corbyn pledges to create state-run generics firm to cut drug prices
22 November 2019 - Labour leader Jeremy Corbyn has included in the party’s election manifesto plans to create a state-run ...
Posted by Michael Wonder on 24 Sep 2019
Drug firms admit to colluding in order to keep prices up
20 September 2019 - Two suppliers of the antidepressant, nortriptyline, have admitted illegally sharing information in order to keep prices up. ...
Posted by Michael Wonder on 13 Dec 2018
Brexit contributes to surge in generic drug prices
13 December 2018 - Calls for government to protect pharmacies. ...
Posted by Michael Wonder on 02 Aug 2018
NHS saved £324 million by switching to biosimilars and generics
2 August 2018 - The UK’s national healthcare provider saved £324 million by switching its patients to “better value” biosimilar ...
Posted by Michael Wonder on 26 Jun 2018
New uses for old drugs
26 June 2018 - Low cost generics are an untapped source of therapeutic innovation. ...
Posted by Michael Wonder on 07 Jun 2017
New UK law to control generic drug prices – implications for pharma
7 June 2017 - New UK regulation seeks to clarify and extend the Government’s powers to regulate the cost of medicines ...
Posted by Michael Wonder on 03 Mar 2017
The scandal of generic drug pricing: drug regulation policies need review
23 February 2017 - We welcome the news that the Competitions and Market Authority is now taking drug companies such as ...